Fulcrum Therapeutics FULC
NASDAQ FULC
$3.69 +0.01 (+0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Fulcrum Therapeutics (FULC) posted Return on Capital Employed [ROCE] of -29.55% for Q2 2026, up 7.84 percentage points from -37.38% a year earlier but down 4.58 percentage points from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Fulcrum Therapeutics' Return on Capital Employed [ROCE] came in at -28.21%, down 19.39 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +48.55 percentage points (FY2020 to FY2025).
  • In prior years, Fulcrum Therapeutics' Return on Capital Employed [ROCE] was -8.82% in FY2024 (+39.60 pp), -48.43% in FY2023 (+4.14 pp), -52.57% in FY2022 (-2.87 pp) and -49.70% in FY2021 (+27.07 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -56.33% in Q2 2022 to a high of -5.12% in Q1 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of +2.61 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 42.89 percentage points; the weakest was Q3 2025, with a drop of 27.58 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -24.97% (Q1 2026), -30.54% (Q4 2025) and -38.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Fulcrum Therapeutics 281.49 Mn 281.49 Mn - -29.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.55%
Mar 31, 2026 -24.97%
Dec 31, 2025 -30.54%
Sep 30, 2025 -38.77%
Jun 30, 2025 -37.38%
Mar 31, 2025 -5.12%
Dec 31, 2024 -8.46%
Sep 30, 2024 -11.19%
Jun 30, 2024 -13.07%
Mar 31, 2024 -48.01%
Dec 31, 2023 -43.46%
Sep 30, 2023 -40.16%
Jun 30, 2023 -36.35%
Mar 31, 2023 -44.13%
Dec 31, 2022 -51.04%
Sep 30, 2022 -52.29%
Jun 30, 2022 -56.33%
Mar 31, 2022 -43.00%
Dec 31, 2021 -35.85%
Sep 30, 2021 -42.75%
API Access

Fulcrum Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FULC&period=max&api_key=YOUR_API_KEY